Natasha Rekhtman
MD, PhD
Attending Pathologist
👥Biography 个人简介
Natasha Rekhtman has standardized HER2 testing in NSCLC pathology, defining criteria for IHC scoring, FISH interpretation, and integration with next-generation sequencing for HER2 detection. Her work supports reliable patient selection for HER2-directed therapies including T-DXd. She advances thoracic pathology biomarker implementation globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Natasha Rekhtman 的研究动态
Follow Natasha Rekhtman's research updates
留下邮箱，当我们发布与 Natasha Rekhtman（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment